The Potassium Supplementation Study

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Cardiovascular HealthCardiovascular Risk Factor
Interventions
DIETARY_SUPPLEMENT

Potassium chloride supplement

Subjects will receive 64 mmol of KCl on the high potassium/high sodium condition.

DIETARY_SUPPLEMENT

Placebo

Subjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet

Trial Locations (1)

19713

RECRUITING

Tower at STAR, Newark

All Listed Sponsors
lead

University of Delaware

OTHER